LEPU BIOPHARMA Names Ren Fangyuan Employee Representative Supervisor After Zhao Lixuan Resignation

Bulletin Express07-15 17:45

LEPU BIOPHARMA CO., LTD. announced that employee representative supervisor Zhao Lixuan resigned effective 15 July 2026 to pursue other professional engagements. Zhao confirmed no disagreements with either the Board of Directors or the Supervisory Board and no matters requiring shareholder attention.

On the same date, the company’s Employee Representatives’ Meeting elected Ren Fangyuan, 25, as the new employee representative supervisor for the remainder of the current Supervisory Board term. Ren joined the Group in August 2025 and serves as an officer in the Securities Business Department. She holds a bachelor’s degree in Finance from Concordia University (May 2023) and a master’s degree in Finance from the University of Rochester (December 2024).

According to the service contract, Ren has no disclosed shareholdings in LEPU BIOPHARMA or its associated corporations, no prior directorships in other listed companies over the past three years, and no relationships with directors, supervisors, senior management or substantial shareholders.

As of 15 July 2026, LEPU BIOPHARMA’s Board consists of Executive Directors Dr. Pu Zhongjie (Chairman) and Dr. Sui Ziye (CEO); Non-executive Directors Ms. Pu Jue and Ms. Qin Yiran; and Independent Non-executive Directors Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198638968?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 17:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198638968","market":"us","top_or_hot":-1,"title":"LEPU BIOPHARMA Names Ren Fangyuan Employee Representative Supervisor After Zhao Lixuan Resignation","media":"Bulletin Express","content":"<p>LEPU BIOPHARMA CO., LTD. announced that employee representative supervisor Zhao Lixuan resigned effective 15 July 2026 to pursue other professional engagements. Zhao confirmed no disagreements with either the Board of Directors or the Supervisory Board and no matters requiring shareholder attention.</p>\n<p>On the same date, the company’s Employee Representatives’ Meeting elected Ren Fangyuan, 25, as the new employee representative supervisor for the remainder of the current Supervisory Board term. Ren joined the Group in August 2025 and serves as an officer in the Securities Business Department. She holds a bachelor’s degree in Finance from Concordia University (May 2023) and a master’s degree in Finance from the University of Rochester (December 2024).</p>\n<p>According to the service contract, Ren has no disclosed shareholdings in LEPU BIOPHARMA or its associated corporations, no prior directorships in other listed companies over the past three years, and no relationships with directors, supervisors, senior management or substantial shareholders.</p>\n<p>As of 15 July 2026, LEPU BIOPHARMA’s Board consists of Executive Directors Dr. Pu Zhongjie (Chairman) and Dr. Sui Ziye (CEO); Non-executive Directors Ms. Pu Jue and Ms. Qin Yiran; and Independent Non-executive Directors Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU BIOPHARMA Names Ren Fangyuan Employee Representative Supervisor After Zhao Lixuan Resignation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU BIOPHARMA Names Ren Fangyuan Employee Representative Supervisor After Zhao Lixuan Resignation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-15 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEPU BIOPHARMA CO., LTD. announced that employee representative supervisor Zhao Lixuan resigned effective 15 July 2026 to pursue other professional engagements. Zhao confirmed no disagreements with either the Board of Directors or the Supervisory Board and no matters requiring shareholder attention.</p>\n<p>On the same date, the company’s Employee Representatives’ Meeting elected Ren Fangyuan, 25, as the new employee representative supervisor for the remainder of the current Supervisory Board term. Ren joined the Group in August 2025 and serves as an officer in the Securities Business Department. She holds a bachelor’s degree in Finance from Concordia University (May 2023) and a master’s degree in Finance from the University of Rochester (December 2024).</p>\n<p>According to the service contract, Ren has no disclosed shareholdings in LEPU BIOPHARMA or its associated corporations, no prior directorships in other listed companies over the past three years, and no relationships with directors, supervisors, senior management or substantial shareholders.</p>\n<p>As of 15 July 2026, LEPU BIOPHARMA’s Board consists of Executive Directors Dr. Pu Zhongjie (Chairman) and Dr. Sui Ziye (CEO); Non-executive Directors Ms. Pu Jue and Ms. Qin Yiran; and Independent Non-executive Directors Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物","start_time":0,"source_url":"","article_id":"1198638968","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198638968","pubTimestamp":1784108728,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LEPU BIOPHARMA CO., LTD. announced that employee representative supervisor Zhao Lixuan resigned effective 15 July 2026 to pursue other professional engagements. Zhao confirmed no disagreements with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物"},"translate_title":"赵立轩辞职后，乐普生物医药任命任方圆为职工代表监事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"LEPU BIOPHARMA CO., LTD. announced that employee representative supervisor Zhao Lixuan resigned effective 15 July 2026 to pursue other professional engagements. Zhao confirmed no disagreements with either the Board of Directors or the Supervisory Board and no matters requiring shareholder attention.\nOn the same date, the company’s Employee Representatives’ Meeting elected Ren Fangyuan, 25, as the new employee representative supervisor for the remainder of the current Supervisory Board term. Ren joined the Group in August 2025 and serves as an officer in the Securities Business Department. She holds a bachelor’s degree in Finance from Concordia University (May 2023) and a master’s degree in Finance from the University of Rochester (December 2024).\nAccording to the service contract, Ren has no disclosed shareholdings in LEPU BIOPHARMA or its associated corporations, no prior directorships in other listed companies over the past three years, and no relationships with directors, supervisors, senior management or substantial shareholders.\nAs of 15 July 2026, LEPU BIOPHARMA’s Board consists of Executive Directors Dr. Pu Zhongjie (Chairman) and Dr. Sui Ziye (CEO); Non-executive Directors Ms. Pu Jue and Ms. Qin Yiran; and Independent Non-executive Directors Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198638968","isCrawlerRequest":true}